Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10 SEK | +2.04% | +3.95% | -10.87% |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 | |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 |
Sales 2024 * | 580M 53.16M | Sales 2025 * | 620M 56.87M | Capitalization | 381M 34.89M |
---|---|---|---|---|---|
Net income 2024 * | 28M 2.57M | Net income 2025 * | 41M 3.76M | EV / Sales 2024 * | 0.79 x |
Net Debt 2024 * | 77.93M 7.14M | Net Debt 2025 * | 75.63M 6.93M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
9.09
x | Employees | 228 |
Yield 2024 * |
2.09% | Yield 2025 * |
3.47% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | +1.43% | ||
1 week | +3.95% | ||
Current month | +0.70% | ||
1 month | +1.63% | ||
3 months | -12.89% | ||
6 months | +8.70% | ||
Current year | -10.87% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | Dec. 31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 20-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 10 | +2.04% | 22 790 |
24-04-26 | 9.8 | +4.03% | 39,281 |
24-04-25 | 9.42 | -1.46% | 19,433 |
24-04-24 | 9.56 | -1.44% | 1,521 |
24-04-23 | 9.7 | +0.83% | 2,928 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 08:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.87% | 34.71M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+1.79% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- BOUL Stock